| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.41▼ | 1.41▼ | 1.41▼ | 1.40▲ | 1.67▼ |
| MA10 | 1.41▼ | 1.42▼ | 1.43▼ | 1.47▼ | 1.45▼ |
| MA20 | 1.42▼ | 1.41▼ | 1.40▼ | 1.65▼ | 1.24▲ |
| MA50 | 1.41▼ | 1.45▼ | 1.52▼ | 1.44▼ | 1.53▼ |
| MA100 | 1.56▼ | 1.69▼ | 1.73▼ | 1.24▲ | 2.35▼ |
| MA200 | 1.78▼ | 1.62▼ | 1.46▼ | 1.43▼ | 4.58▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.005▲ | 0.009▲ | -0.051▼ | 0.074▲ |
| RSI | 45.417▼ | 44.190▼ | 43.231▼ | 42.536▼ | 50.310▲ |
| STOCH | 44.583 | 24.583 | 24.792 | 13.763▼ | 48.629 |
| WILL %R | -93.750▼ | -93.750▼ | -75.000▼ | -85.294▼ | -67.722 |
| CCI | -108.889▼ | -103.704▼ | -79.167 | -77.644 | 13.590 |
|
Thursday, November 13, 2025 10:25 AM
ImmunoScape announced an in-licensing deal with Cue Biopharma to lead the development of a new class of therapies to attack solid tumor cancers.
|
|
Wednesday, November 12, 2025 04:17 AM
First-in-class dendritic cell (DC) maturation agent Plinabulin drives immune re-sensitization in metastatic NSCLC ...
|
|
Tuesday, November 11, 2025 04:07 AM
SAN DIEGO, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 1.35 | 1.42 | 1.35 | 1.42 | 12,200 |
| 13/11/25 | 1.35 | 1.48 | 1.35 | 1.39 | 36,800 |
| 12/11/25 | 1.35 | 1.43 | 1.33 | 1.41 | 25,200 |
| 11/11/25 | 1.42 | 1.46 | 1.32 | 1.38 | 81,300 |
| 10/11/25 | 1.46 | 1.53 | 1.41 | 1.41 | 127,700 |
| 07/11/25 | 1.44 | 1.48 | 1.43 | 1.45 | 83,600 |
| 06/11/25 | 1.51 | 1.54 | 1.45 | 1.48 | 27,510 |
| 05/11/25 | 1.49 | 1.57 | 1.48 | 1.55 | 39,300 |
| 04/11/25 | 1.55 | 1.63 | 1.48 | 1.53 | 67,100 |
| 03/11/25 | 1.62 | 1.79 | 1.52 | 1.65 | 252,900 |
|
|
||||
|
|
||||
|
|